6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one Basic information
- Product Name:
- 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one
- Synonyms:
-
- Oxindole-6-boronic acid, pinacol ester
- 2-Oxoindoline-6-boronic Acid Pinacol Ester
- 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indol-2-one
- 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one
- 6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-1,3-dihydro-indol-2-one
- 2H-Indol-2-one, 1,3-dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
- Oxindole-6-boronic
- 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one - [T26256]
- CAS:
- 893441-85-5
- MF:
- C14H18BNO3
- MW:
- 259.11
- EINECS:
- 200-589-5
- Mol File:
- 893441-85-5.mol
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one Chemical Properties
- Density
- 1.16±0.1 g/cm3 (20 ºC 760 Torr)
- storage temp.
- under inert gas (nitrogen or Argon) at 2-8°C
- Appearance
- White to yellow Solid
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one Usage And Synthesis
Uses
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one is useful for preparation of imidazopyridazines as therapeutic kinase inhibitors.
Synthesis
99365-40-9
73183-34-3
893441-85-5
The general procedure for the synthesis of 2-oxoindoline-6-boronic acid pinacol ester from 6-bromo-2-indolone and bis(pinacolato)diboron (898 mg, 3.54 mmol), potassium acetate (694 mg, 7.07 mmol) and Pd(dppf)Cl2-CH2Cl2 (96.0 mg, 0.118 mmol). The above mixture was dissolved in 1,2-dimethoxyethane (DME, 17 mL). The reaction system was heated and reacted at 80 °C overnight. Upon completion of the reaction, the contents of the four reaction vials were combined, the reaction solution was concentrated and purified by column chromatography (cyclohexane/ethyl acetate as eluent) to afford the target compound, 2-oxoindoline-6-boronic acid pinacol ester, as a white solid (2.27 g, 75% yield, 80% purity). The structure of the product was confirmed by 1H NMR (500 MHz, CDCl3): δ 8.57 (broad single peak, 1H), 7.48 (double peak, J=7.3 Hz, 1H), 7.31 (single peak, 1H), 7.23 (double peak, J=7.3 Hz, 1H), 3.55 (single peak, 2H), 1.33 (single peak, 12H).LC-MS (ESI, m/z) analysis showed that: retention time was 0.5 mm. z) analysis showed retention time Rt = 2.75 min and molecular ion peak m/z = 260 ([M+H]+, HPLC method E).
References
[1] Patent: WO2015/144290, 2015, A1. Location in patent: Page/Page column 85
[2] Patent: WO2015/39172, 2015, A1. Location in patent: Page/Page column 60
[3] Patent: WO2011/15641, 2011, A1. Location in patent: Page/Page column 128
[4] Patent: WO2011/101640, 2011, A1. Location in patent: Page/Page column 106
[5] Patent: WO2008/23161, 2008, A1. Location in patent: Page/Page column 120
6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-oneSupplier
- Tel
- 021-021-58432009 400-005-6266
- sales8178@energy-chemical.com
- Tel
- 86-027-67849912
- sales@chemwish.com
- Tel
- 18986259541
- sales@3stc.com
- Tel
- 025-66113011 17798518460
- cfzhang@aikonchem.com
- Tel
- sales@witofly.com